Gerald Higgins, MD, PhD
Dr. Higgins has served in corporate, hospital, federal and academic research settings. He has 2 doctorates and an MD (psychiatry), but does not practice medicine. He has served as Chief of Molecular Neurobiology at the National Institutes of Health (NIND; NIA), U.S. VP of R&D for Roche, CMIO at MedStar Health (9 hospitals including Georgetown and Washington Hospital Ctr), IPA at the Defense Advanced Research Projects Agency (DARPA), and most recently as VP of Pharmacogenomics at Assurex Health, now a subsidiary of Myriad Genetics. He also co-founded SimQuest International, served as President and CEO, and sold the company to Laerdal Medical Corporation. He has received both federal grants and contracts (24), and raised substantial private equity funding. He has over 200 peer-reviewed publications.